Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 1

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 1
---
 Emerging Growth Company" and "Offering Circular Summary-Implications of Being a Smaller Reporting Company."

<div align='center'>______________________</div>

This offering is being conducted on a “best-efforts” basis, which means that there is no minimum number of Units that must be sold by us for this offering to close; thus, we may receive no or minimal proceeds from this offering. None of the proceeds received will be placed in an escrow or trust account. All proceeds from this offering will become immediately available to us and may be used as they are accepted. Purchasers of the Units will not be entitled to a refund and could lose their entire investments.

We estimate that this offering will commence within two days of SEC qualification; this offering will terminate at the earliest of (a) the date on which the maximum offering has been sold, (b) one year from the date of SEC qualification, or (c) the date on which this offering is earlier terminated by us, in our sole discretion. See “Plan of Distribution”.

Investing in our securities involves risks. See "Risk Factors" beginning on page 9 of this offering circular.

|                           | Per Unit |     |      Total |
| Public offering price     |    $2.80 |     | $4,172,000 |
| Commissions(1)            |    $0.21 |     |   $312,900 |
| Proceeds, before expenses |    $2.59 |     | $3,859,100 |

(1)We have engaged Maxim Group LLC and Brookline Capital Markets, a division of Arcadia Securities, LLC (together, the “Placement Agents”) to act as placement agents for this offering, in exchange for a fee of 7.5% of the aggregate offering price of the Units sold in this offering.

The United States Securities and Exchange Commission does not pass upon the merits of or give its approval to any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering circular or other solicitation materials. These securities are offered pursuant to an exemption from registration with the SEC; however, the SEC has not made an independent determination that the securities offered are exempt from registration.

Generally, no sale may be made to you in this offering if the aggregate purchase price you pay is more than 10% of the greater of your annual income or net worth. Different rules apply to accredited investors and non-natural persons. Before making any representation that your investment does